Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene refers to a nonfunctional genomic sequence that closely resembles the ribosomal protein L36 gene (RPL36) but lacks the ability to produce a functional ribosomal protein. Pseudogenes arise through processes such as gene duplication, retrotransposition, or disabling mutations and are identified by their sequence homology to known functional genes, along with disruptions (e.g., premature stop codons or frameshifts) that prevent normal gene expression and protein production. The majority of RPL36 pseudogenes are processed, meaning they originate from reverse-transcribed mRNA copies reintegrated into the genome without regulatory regions, and they typically lack biological function. In rare cases, pseudogenes may be transcribed and exert minor regulatory roles, but these do not apply to drug targeting or classical molecular functions[1][3][5][6].\n\nKey notes:\n- Pseudogenes like ribosomal protein L36 pseudogene are prevalent in the genome but are generally regarded as \"junk DNA\" with no protein-coding potential and not active in disease or drug response[5][1].\n- Occasionally, pseudogenes may play regulatory or RNA-mediated roles, but there is no evidence of clinical or therapeutic impact for RPL36 pseudogenes specifically[1][7].\n- It is important not to confuse these with functional ribosomal protein genes, such as RPL36, which do have crucial biological roles[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene.